Business Wire

Cognite Announces New Leaders to Continue Driving AI Innovation and Accelerate Industrial Value Realization

20.5.2025 15:02:00 CEST | Business Wire | Press Release

Share

Cognite, the global leader in industrial AI, today announced two strategic appointments to deliver more innovation with the AI ecosystem and customer value: Co-founder Geir Engdahl, as Chief Technology Officer, AI, and James Sirota as Global Head of Engineering. Engdahl will lead the company's AI First technology strategy. Sirota will spearhead the worldwide engineering functions, driving the rapid delivery of new capabilities and scaling of Cognite’s industrial AI and data platform Cognite Data Fusion® and the transformative industrial workbench Cognite Atlas AI™.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519865188/en/

James Sirota named Global Head of Engineering and Geir Engdahl, CTO, AI.

Since the company's founding, Engdahl has been pivotal in creating the only scalable and open AI platform specifically built for the demanding range and volume of industrial data. Cognite's unique architecture and capabilities have enabled customers to reap significant ROI from increasing production, reducing downtime, and accelerating sustainability. In this new role, he will return to his disruptive founder roots to extend Cognite's AI technology to deliver more real-time intelligence from any data, on any hyperscaler, and leveraging any LLM at scale.

Sirota joins Cognite as the company aggressively accelerates its delivery of intelligent, AI-powered applications to unlock the true potential of industrial data for decision-makers and domain experts across manufacturing, energy, and power generation verticals. Cognite's solutions are the key to enabling AI by liberating data from silos and making it AI-ready, forging a path towards real-time, scalable agentic AI-driven operations.

"Cognite is raising the bar on the next generation of AI First technology and development in order to help companies achieve more of their AI transformation goals and business outcomes. We welcome James to our executive team at such a transformative time for both Cognite and the industrial sector," said Girish Rishi, CEO at Cognite. "James' proven expertise in scaling engineering organizations and delivering AI-powered platforms, combined with Geir's innovation leadership and our previously announced CPO Chirayu Shah's product vision, will be vital as we continue to expand our global footprint and help industrial companies realize even more value from agentic AI, their industrial data and operations."

"I am thrilled to lead the charge for this next phase of AI innovation," said Geir Engdahl, CTO, AI at Cognite. "Being at the forefront and co-innovating with the global hyperscalers and LLM providers will unlock more value from agentic AI and all industrial data that are uniquely accessible in our platform."

Engdahl previously founded Snapsale in 2011, a classifieds AI startup. He led the company as CEO and CTO until the company was acquired by Schibsted in 2017. He also served as a senior software engineer for Google where he developed AI capabilities for targeting and conversion optimization in their advertising systems. Engdahl has a master's degree in computational science from the University of Oslo and received a silver medal from the International Olympiad in Informatics.

"Industrial enterprises generate enormous volumes of operational data, but often struggle to extract meaningful insights from it," said James Sirota, Global Head of Engineering at Cognite. "They need a robust platform to explore this data effectively, combined with powerful AI capabilities to identify trends and insights more efficiently. What drew me to Cognite was how their products address this exact challenge. Cognite is not only solving deeply technical problems—it's solving meaningful ones for the industrial sector. My job is to make sure our engineers are equipped, empowered, and inspired to deliver products that transform how the industrial sector works."

With over 20 years of leadership in software engineering and AI, Sirota brings a combination of technical depth and global execution excellence to Cognite. Having previously led engineering organizations at AWS, Cloudera, and Cisco, he brings extensive experience scaling enterprise software platforms and high-performing global teams. His passion for building cohesive, empowered engineering teams and high-scale platforms aligns directly with Cognite's vision. As the company continues its rapid global expansion, Sirota's leadership will be central to delivering innovative, AI-driven solutions that power the future of industry.

About Cognite

Cognite makes GenAI work for industry. Leading energy, manufacturing, and power & renewables enterprises choose Cognite to deliver secure, trustworthy, and real-time data to transform their asset-heavy operations to be safer, more sustainable, and profitable. Cognite provides a user-friendly, secure, and scalable platform that makes it easy for all decision-makers, from the field to remote operations centers, to access and understand complex industrial data, collaborate in real-time, and build a better tomorrow. Visit us at www.cognite.com and follow us on LinkedIn and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250519865188/en/

Contacts

Media Contact
Michelle Holford
Vice President, Global PR
michelle.holford@Cognite.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye